Completed × Observational × Lung Diseases, Interstitial × Clear all Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Completed
1,149 enrolled
IMFINZI Specific-Clinical Experience Investigation in Patients With NSCLC After Definitive Chemoradiation Therapy
Completed
634 enrolled
ILD
Completed
36 enrolled
CARES
Completed
744 enrolled
EXHALE 1B
Completed
37 enrolled
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Completed
1,149 enrolled
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Completed
4,626 enrolled
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Completed
361 enrolled
Respiratory Endoscopy: Diagnostic Yield, Technical Factors and Complications
Completed
4,000 enrolled
ILAs in CT Lung Cancer Screening Population
Completed
1,703 enrolled
PREVENT
Completed
27 enrolled
Predictors for Bronchoalveolar Lavage (BAL) Recovery Rate Derived From Quantified Computed Tomography (qCT)
Completed
33 enrolled
Q-BC
Completed
600 enrolled
Blood Collection From Individuals With Lung Disease for Genetic Studies
Completed
3,087 enrolled
The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease
Completed
1,375,842 enrolled